ClearPoint Neuro (CLPT) Liabilities and Shareholders Equity (2011 - 2026)
ClearPoint Neuro recorded quarterly Liabilities and Shareholders Equity of $93.4 million in Q1 2026, down 4.43% quarter-over-quarter from $97.7 million in Q4 2025, and up 210.66% year-over-year from $30.1 million in Q1 2025.
ClearPoint Neuro's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $93.4 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 210.66% year-over-year to $93.4 million; the TTM figure through Mar 2026 stood at $314.4 million (up 94.04% YoY), while the FY2025 annual figure was $97.7 million, up 149.42% from the prior year.
- Liabilities and Shareholders Equity came in at $93.4 million for Q1 2026 at ClearPoint Neuro, down from $97.7 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $97.7 million in Q4 2025 to a low of $30.1 million in Q1 2025.
- A 5-year average of $55.9 million and a median of $53.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 43.94% in 2025 and soared 210.66% in 2026, its largest moves.
- ClearPoint Neuro's Liabilities and Shareholders Equity stood at $55.5 million in 2022, then slipped by 23.12% to $42.7 million in 2023, then retreated by 8.14% to $39.2 million in 2024, then soared by 149.42% to $97.7 million in 2025, then declined by 4.43% to $93.4 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $93.4 million, $97.7 million, and $60.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 93.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.42 Mn |
| Dec 31, 2025 | 97.75 Mn |
| Sep 30, 2025 | 60.36 Mn |
| Jun 30, 2025 | 62.87 Mn |
| Mar 31, 2025 | 30.07 Mn |
| Dec 31, 2024 | 39.19 Mn |
| Sep 30, 2024 | 40.19 Mn |
| Jun 30, 2024 | 52.57 Mn |
| Mar 31, 2024 | 53.64 Mn |
| Dec 31, 2023 | 42.66 Mn |
| Sep 30, 2023 | 43.84 Mn |
| Jun 30, 2023 | 47.64 Mn |
| Mar 31, 2023 | 50.25 Mn |
| Dec 31, 2022 | 55.49 Mn |
| Sep 30, 2022 | 57.74 Mn |
| Jun 30, 2022 | 60.24 Mn |
| Mar 31, 2022 | 61.77 Mn |
| Dec 31, 2021 | 65.58 Mn |
| Sep 30, 2021 | 68.70 Mn |
| Jun 30, 2021 | 72.33 Mn |
| Mar 31, 2021 | 74.26 Mn |
| Dec 31, 2020 | 29.52 Mn |
| Sep 30, 2020 | 21.85 Mn |
| Jun 30, 2020 | 23.03 Mn |
| Mar 31, 2020 | 23.59 Mn |
| Dec 31, 2019 | 11.93 Mn |
| Sep 30, 2019 | 13.39 Mn |
| Jun 30, 2019 | 13.27 Mn |
| Mar 31, 2019 | 7.63 Mn |
| Dec 31, 2018 | 7.86 Mn |
| Sep 30, 2018 | 8.68 Mn |
| Jun 30, 2018 | 11.59 Mn |
| Mar 31, 2018 | 12.35 Mn |
| Dec 31, 2017 | 13.90 Mn |
| Dec 31, 2016 | 7.40 Mn |
| Sep 30, 2016 | 9.01 Mn |
| Jun 30, 2016 | 6.44 Mn |
| Mar 31, 2016 | 8.29 Mn |
| Dec 31, 2015 | 9.94 Mn |
| Sep 30, 2015 | 6.27 Mn |
| Jun 30, 2015 | 7.86 Mn |
| Mar 31, 2015 | 10.75 Mn |
| Dec 31, 2014 | 13.39 Mn |
| Sep 30, 2014 | 6.50 Mn |
| Jun 30, 2014 | 8.48 Mn |
| Mar 31, 2014 | 10.05 Mn |
| Dec 31, 2013 | 7.87 Mn |
| Sep 30, 2013 | 9.52 Mn |
| Jun 30, 2013 | 10.99 Mn |
| Mar 31, 2013 | 13.02 Mn |
| Dec 31, 2012 | 5.55 Mn |
| Sep 30, 2012 | 7.49 Mn |
| Jun 30, 2012 | 4.83 Mn |
| Mar 31, 2012 | 4.07 Mn |
| Dec 31, 2011 | 3.03 Mn |